Iopidine

Iopidine is a brand name of apraclonidine ophthalmic, approved by the FDA in the following formulation(s):

IOPIDINE (apraclonidine hydrochloride - solution/drops; ophthalmic)

• 
  Manufacturer: ALCON
  
  Approval date: December 31, 1987
  
  Strength(s): EQ 1% BASE ^[RLD]


• 
  Manufacturer: ALCON
  
  Approval date: July 30, 1993
  
  Strength(s): EQ 0.5% BASE ^[RLD][AT]

Has a generic version of Iopidine been approved?

Yes. The following products are equivalent to Iopidine:

apraclonidine hydrochloride solution/drops; ophthalmic

• 
  Manufacturer: AKORN INC
  
  Approval date: March 12, 2009
  
  Strength(s): EQ 0.5% BASE ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Iopidine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Iopidine.

See also...

• Iopidine Drops Consumer Information (Wolters Kluwer)
• Iopidine Consumer Information (Cerner Multum)
• Iopidine Advanced Consumer Information (Micromedex)
• Iopidine AHFS DI Monographs (ASHP)
• Apraclonidine Drops Consumer Information (Wolters Kluwer)
• Apraclonidine ophthalmic Consumer Information (Cerner Multum)
• Apraclonidine Ophthalmic Advanced Consumer Information (Micromedex)
• Apraclonidine Hydrochloride AHFS DI Monographs (ASHP)